Clinical trial

Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia; Finding the Optimum Combination

Name
MRC-01-18-157
Description
Epidural Analgesia remains the most effective form of pain relief in labour. After initiating epidural analgesia, there are many epidural drug regimens that can be employed to maintain analgesia for the duration of labour using an epidural catheter. Due to recent advances in medical technology, new epidural pumps, which allow both patient controlled epidural analgesia boluses (PCEA, a common standard of care in many hospitals) and programmed intermittent epidural boluses (PIEB, automatic boluses given in addition to the PCEA bolus), are now available. In this randomized double-blind trial, we aim to evaluate the effects of different combinations of PIEB (epidural bolus volume) and PIEB (bolus volume and time interval) on labour patient-controlled epidural analgesia (PCEA) usage. In theory, the more effective the PIEB combination (the ideal drug volume and ideal time interval), the less PCEA boluses (extra epidural drug) will be used as well as less clinician boluses and less lower limb weakness (motor block) as assessed by the Bromage Score.
Trial arms
Trial start
2024-02-20
Estimated PCD
2024-04-20
Trial end
2024-04-30
Status
Not yet recruiting
Phase
Early phase I
Treatment
Levobupivacaine and Fentanyl
Programmed Intermittent Epidural Bolus
Arms:
Group 1, Group 2, Group 3, Group 4, Group 5, Group 6, Group 7, Group 8
Size
200
Primary endpoint
The volume of local anaesthetic mixture for breakthrough pain (PCEA + clinician bolus) + the Bromage Score
From the siting of the epidural block to the delivery of the fetus (maximum 24 hrs)
Eligibility criteria
Inclusion Criteria: * Age 18 to 50 yrs * In active labour * ASA 2 patients (pregnant patients are considered to be ASA 2) * Singleton pregnancy * \> 37 weeks gestation * Booking BMI 18 to 35 Exclusion Criteria: * BMI \< 18 * BMI \> 35 * Systemic opioids within the previous 6 hours * Presence of a fetal anomaly * Pre-eclampsia * Bleeding disorders (including coagulation disorders) * Recent spinal surgery * Spinal injury * Elevated intracranial pressure (ICP) * Neuraxial disorders of any description * Signs of local or systemic infection * Patient refusal for neuraxial analgesia
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'SEQUENTIAL', 'interventionModelDescription': 'We aim to use a pragmatic sequential optimization method as described by Sveticic et al. 2003. For the first round of recruitment, the research team will randomize women into 8 different groups of PIEB/PCEA regimens with six (n=6) women per group and set up the epidural pump for the maintenance of labor analgesia. This first round of recruitment will be called Complex #1. The PCEA bolus volume and lockout interval will stay the same for all groups.\n\nThere will be 8 combinations of PIEB/PCEA using an epidural mixture of 0.1% levobupivacaine + 2mcg/ml Fentanyl (n=48). We will exclude the 2 worst performing groups (as assessed by our composite primary outcome). Using sequential optimization, 2 new groups with different combinations of PIEB volume / interval will be added to the remaining 6 groups. Complex 2 therefore will consist of 8 groups of 48 patients (n=6 per group). We anticipate 3 to 4 rounds of recruitment until our statistician determines the 2 best performing groups.', 'primaryPurpose': 'HEALTH_SERVICES_RESEARCH', 'maskingInfo': {'masking': 'TRIPLE', 'maskingDescription': 'This is a randomized double-blinded design. Patients and their attending physicians / clinical anaesthetists / data collection study member / midwives / nurses will be blinded to patient group allocation', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 200, 'type': 'ESTIMATED'}}
Updated at
2024-02-20

1 organization

2 products

3 indications

Indication
Labour Pain
Indication
Obstetric Pain
Indication
Analgesic